Current Update on PET/MRI in Gynecological Malignancies—A Review of the Literature

Virarkar, Mayur; Vulasala, Sai Swarupa R; Calimano-Ramirez, Luis; Singh, Anmol; Lall, Chandana; Bhosale, Priya

doi:10.3390/curroncol30010083

Cited by 3 publications

(1 citation statement)

References 113 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Various imaging modalities, including ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), functional MRI, and combined imaging with positron emission tomography (PET/MRI) and positron-emission-tomography-computed tomography (PET-CT), are employed for the management of common gynecologic malignancies, specifically cervical, endometrial, and ovarian malignancies [4]. Recent advancements in imaging, such as 18F-fluorodeoxyglucose positron-emission-computed tomography (18F-FDG PET/CT) and 18F-FDG-PET/MRI, have significantly contributed to the characterization and management of gynecological malignancies [5]. While the use of FDG PET/CT for gynecological cancer management is not mandatory, it has been recommended in the Danish Gynecological Cancer Ovarian Guidelines since 2009 for evaluating women with suspected ovarian cancer.…”

Section: Introductionmentioning

confidence: 99%

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature

Allahqoli,

Hakimi,

Laganà

et al. 2023

J. Imaging

View full text Add to dashboard Cite

Objective: Positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro- D-glucose integrated with computed tomography (18F-FDG PET/CT) or magnetic resonance imaging (18F-FDG PET/MRI) has emerged as a promising tool for managing various types of cancer. This review study was conducted to investigate the role of 18F- FDG PET/CT and FDG PET/MRI in the management of gynecological malignancies. Search strategy: We searched for relevant articles in the three databases PubMed/MEDLINE, Scopus, and Web of Science. Selection criteria: All studies reporting data on the FDG PET/CT and FDG PET MRI in the management of gynecological cancer, performed anywhere in the world and published exclusively in the English language, were included in the present study. Data collection and analysis: We used the EndNote software (EndNote X8.1, Thomson Reuters) to list the studies and screen them on the basis of the inclusion criteria. Data, including first author, publication year, sample size, clinical application, imaging type, and main result, were extracted and tabulated in Excel. The sensitivity, specificity, and diagnostic accuracy of the modalities were extracted and summarized. Main results: After screening 988 records, 166 studies published between 2004 and 2022 were included, covering various methodologies. Studies were divided into the following five categories: the role of FDG PET/CT and FDG-PET/MRI in the management of: (a) endometrial cancer (n = 30); (b) ovarian cancer (n = 60); (c) cervical cancer (n = 50); (d) vulvar and vagina cancers (n = 12); and (e) gynecological cancers (n = 14). Conclusions: FDG PET/CT and FDG PET/MRI have demonstrated potential as non-invasive imaging tools for enhancing the management of gynecological malignancies. Nevertheless, certain associated challenges warrant attention.

show abstract

Section: Introductionmentioning

confidence: 99%

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature

Allahqoli,

Hakimi,

Laganà

et al. 2023

J. Imaging

View full text Add to dashboard Cite

show abstract

Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer

Puranik,

Choudhury,

Ghosh

et al. 2024

Indian Journal of Cancer

View full text Add to dashboard Cite

PET/CT and radioisotope therapy are diagnostic and therapeutic arms of Nuclear Medicine, respectively. With the emergence of better technology, PET/CT has become an accessible modality. Diagnostic tracers exploring disease-specific targets has led the clinicians to look beyond FDG PET. Moreover, with the emergence of theranostic pairs of radiopharmaceuticals, radioisotope therapy is gradually making it’s way into treatment algorithm of common cancers in India. We therefore would like to discuss in detail the updates in PET/CT imaging and radionuclide therapy and generate a consensus-driven evidence based document which would guide the practitioners of Oncology.

show abstract

PET/MRI in Gynecologic Cancers: How Helpful is it?

Erden,

Kuru Öz,

Soydal

et al. 2024

trs

View full text Add to dashboard Cite

Current Update on PET/MRI in Gynecological Malignancies—A Review of the Literature

Cited by 3 publications

References 113 publications

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature

Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer

PET/MRI in Gynecologic Cancers: How Helpful is it?

Contact Info

Product

Resources

About